AI MARKET SCANNING

Kala Bio Inc

📅 Next Catalyst: Nov 17, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.11%
MAX GAP RECORD +5.01%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $KALA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 17, 2026 Earnings Release 2026-11-17 (AFTER CLOSE) 🔮 UPCOMING 🔒
Nov 19, 2025 Earnings Release 2025-11-19 (BEFORE OPEN)
+0.15%
Aug 08, 2025 Earnings Release 2025-08-08 (BEFORE OPEN)
-0.56%
May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE)
-0.31%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
-0.99%
Aug 06, 2024 Earnings Release 2024-08-06 (AFTER CLOSE)
-1.29%
May 14, 2024 Earnings Release 2024-05-14 (AFTER CLOSE)
-2.26%
Mar 28, 2024 Earnings Release 2024-03-28 (BEFORE OPEN)
-0.25%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.4%
Bullish Gaps (3)
Bearish Gaps (3)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $KALA

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗